Download PDF
J Pediatr Intensive Care 2020; 09(02): 119-123
DOI: 10.1055/s-0039-3400458
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Management of Hyperactive Delirium in the Pediatric Intensive Care Unit: Case Series of Three Young Children

Anna O. Jesus
1   Division of Neurodevelopmental and Behavioral Pediatrics, University of Virginia, Charlottesville, Virginia, United States
,
Lotte Jones
2   Division of Pediatric Critical Care, Children's Hospital of the King's Daughters, Norfolk, Virginia, United States
,
Rebecca Linares
3   Division of Pediatric Critical Care, University of Virginia, Charlottesville, Virginia, United States
,
Marcia L. Buck
4   American College of Clinical Pharmacy, Washington, DC, United States
,
Deborah U. Frank
3   Division of Pediatric Critical Care, University of Virginia, Charlottesville, Virginia, United States
› Author Affiliations
Further Information

Publication History

28 June 2019

12 October 2019

Publication Date:
21 November 2019 (online)

    Permissions and Reprints

Abstract

Children in the intensive care unit (ICU) are at high risk of developing delirium, given their underlying disease processes, the adverse effects of treatments and medications, and the stressful, abnormal environment. If prevention and nonpharmacologic measures to treat delirium are unsuccessful, atypical antipsychotics are considered, although they are not approved by Food and Drug Administration for the treatment of pediatric delirium and could have significant adverse side effects. This case report presents three pediatric patients with hyperactive ICU delirium that risked life-threating complications who were successfully treated with short courses of atypical antipsychotic medications.

Keywords

pediatric - delirium - antipsychotic
 

  • References

  • 1 Schieveld JN, Janssen NJ. Delirium in the pediatric patient: on the growing awareness of its clinical interdisciplinary importance. JAMA Pediatr 2014; 168 (07) 595-596
    CrossrefPubMedGoogle Scholar
  • 2 Silver G, Traube C, Gerber LM. , et al. Pediatric delirium and associated risk factors: a single-center prospective observational study. Pediatr Crit Care Med 2015; 16 (04) 303-309
    CrossrefPubMedGoogle Scholar
  • 3 Traube C, Silver G, Reeder RW. , et al. Delirium in critically ill children: an international point prevalence study. Crit Care Med 2017; 45 (04) 584-590
    CrossrefPubMedGoogle Scholar
  • 4 Patel AK, Bell MJ, Traube C. Delirium in pediatric critical care. Pediatr Clin North Am 2017; 64 (05) 1117-1132
    CrossrefPubMedGoogle Scholar
  • 5 Turkel SB. Pediatric delirium: recognition, management, and outcome. Curr Psychiatry Rep 2017; 19 (12) 101
    CrossrefPubMedGoogle Scholar
  • 6 Uçok A, Gaebel W. Side effects of atypical antipsychotics: a brief overview. World Psychiatry 2008; 7 (01) 58-62
    CrossrefPubMedGoogle Scholar
  • 7 Girard TD, Exline MC, Carson SS. , et al; MIND-USA Investigators. Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med 2018; 379 (26) 2506-2516
    CrossrefPubMedGoogle Scholar
  • 8 Hui TS, Wong A, Wijesinghe R. A review on mortality risks associated with antipsychotic use in behavioral and psychologic symptoms of dementia (BPSD). Ment Health Clin 2016; 6 (05) 215-221
    PubMedGoogle Scholar
  • 9 Ray WA, Stein CM, Murray KT. , et al. Association of antipsychotic treatment with risk of unexpected death among children and youths. JAMA Psychiatry 2019; 76 (02) 162-171
    CrossrefPubMedGoogle Scholar
  • 10 Traube C, Augenstein J, Greenwald B, LaQuaglia M, Silver G. Neuroblastoma and pediatric delirium: a case series. Pediatr Blood Cancer 2014; 61 (06) 1121-1123
    CrossrefPubMedGoogle Scholar
  • 11 Skrobik Y, Duprey MS, Hill NS, Devlin JW. Low-dose nocturnal dexmedetomidine prevents icu delirium. a randomized, placebo-controlled trial. Am J Respir Crit Care Med 2018; 197 (09) 1147-1156
    CrossrefPubMedGoogle Scholar
  • 12 Zhu M, Wang H, Zhu A, Niu K, Wang G. Meta-analysis of dexmedetomidine on emergence agitation and recovery profiles in children after sevoflurane anesthesia: different administration and different dosage. PLoS One 2015; 10 (04) e0123728
    CrossrefPubMedGoogle Scholar
  • 13 Devlin JW, Roberts RJ, Fong JJ. , et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010; 38 (02) 419-427
    CrossrefPubMedGoogle Scholar
  • 14 Traube C, Witcher R, Mendez-Rico E, Silver G. Quetiapine as treatment for delirium in critically ill children: a case series. J Pediatr Intensive Care 2013; 2 (03) 121-126
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Silver GH, Kearney JA, Kutko MC, Bartell AS. Infant delirium in pediatric critical care settings. Am J Psychiatry 2010; 167 (10) 1172-1177
    CrossrefPubMedGoogle Scholar
  • 16 Joyce C, Witcher R, Herrup E. , et al. Evaluation of the safety of quetiapine in treating delirium in critically ill children: a retrospective review. J Child Adolesc Psychopharmacol 2015; 25 (09) 666-670
    CrossrefPubMedGoogle Scholar
  • 17 Turkel SB, Jacobson JR, Tavaré CJ. The diagnosis and management of delirium in infancy. J Child Adolesc Psychopharmacol 2013; 23 (05) 352-356
    CrossrefPubMedGoogle Scholar
  • 18 Edwards LE, Hutchison LB, Hornik CD, Smith PB, Cotten CM, Bidegain M. A case of infant delirium in the neonatal intensive care unit. J Neonatal Perinatal Med 2017; 10 (01) 119-123
    CrossrefPubMedGoogle Scholar
  • 19 Smith HA, Gangopadhyay M, Goben CM. , et al. The preschool confusion assessment method for the ICU: valid and reliable delirium monitoring for critically ill infants and children. Crit Care Med 2016; 44 (03) 592-600
    CrossrefPubMedGoogle Scholar
  • 20 Kelly P, Frosch E. Recognition of delirium on pediatric hospital services. Psychosomatics 2012; 53 (05) 446-451
    CrossrefPubMedGoogle Scholar
  • 21 Smith HA, Boyd J, Fuchs DC. , et al. Diagnosing delirium in critically ill children: validity and reliability of the pediatric confusion assessment method for the Intensive Care Unit. Crit Care Med 2011; 39 (01) 150-157
    CrossrefPubMedGoogle Scholar
  • 22 Traube C, Silver G, Kearney J. , et al. Cornell Assessment of Pediatric Delirium: a valid, rapid, observational tool for screening delirium in the PICU*. Crit Care Med 2014; 42 (03) 656-663
    CrossrefPubMedGoogle Scholar
  • 23 Silver G, Kearney J, Traube C, Hertzig M. Delirium screening anchored in child development: the Cornell Assessment for Pediatric Delirium. Palliat Support Care 2015; 13 (04) 1005-1011
    CrossrefPubMedGoogle Scholar
  • 24 Brahmbhatt K, Whitgob E. Diagnosis and management of delirium in critically ill infants: case report and review. Pediatrics 2016; 137 (03) e20151940
    CrossrefPubMedGoogle Scholar
  • 25 Ratcliff SL, Meyer III WJ, Cuervo LJ, Villarreal C, Thomas CR, Herndon DN. The use of haloperidol and associated complications in the agitated, acutely ill pediatric burn patient. J Burn Care Rehabil 2004; 25 (06) 472-478
    CrossrefPubMedGoogle Scholar
  • 26 Turkel SB, Jacobson J, Munzig E, Tavaré CJ. Atypical antipsychotic medications to control symptoms of delirium in children and adolescents. J Child Adolesc Psychopharmacol 2012; 22 (02) 126-130
    CrossrefPubMedGoogle Scholar
  • 27 Rummel-Kluge C, Komossa K, Schwarz S. , et al. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res 2010; 123 (2,3): 225-233
    CrossrefPubMedGoogle Scholar
  • 28 Turkel SB, Hanft A. The pharmacologic management of delirium in children and adolescents. Paediatr Drugs 2014; 16 (04) 267-274
    CrossrefPubMedGoogle Scholar